Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zanninelli

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular and Cellular Biology|August 24, 1999
The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytesH Talarmin, C Rescan, S Cariou, et al.
European Journal of Clinical Investigation|February 10, 2009
Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosisG Latella, A Vetuschi, R Sferra, et al.
Journal of Hepatology|July 1, 1997
Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in ratsG Zanninelli, R Choudury, O Loréal, et al.
Molecular Pharmacology|May 1, 1997
Chelation and mobilization of cellular iron by different classes of chelatorsG Zanninelli, H Glickstein, W Breuer, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular and Cellular Biology|August 24, 1999
The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytesH Talarmin, C Rescan, S Cariou, et al.
European Journal of Clinical Investigation|February 10, 2009
Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosisG Latella, A Vetuschi, R Sferra, et al.
Journal of Hepatology|July 1, 1997
Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in ratsG Zanninelli, R Choudury, O Loréal, et al.
Molecular Pharmacology|May 1, 1997
Chelation and mobilization of cellular iron by different classes of chelatorsG Zanninelli, H Glickstein, W Breuer, et al.
Pageof 2